Pay in 4 interest-free payments of $5.30 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
Superoxide dismutase B (SodB) H
While historically listed with an "unknown status," recent data releases in late 2025 and early 2026 have clarified the safety profile that helped justify the Category 1 reclassification. Study Design: A randomized, placebo-controlled, double-blind Phase 1 pilot study
Individuals with severe kidney or liver disease, unless closely monitored and approved by a healthcare provider
Researchers losing weight rapidly should be aware of symptoms including right upper quadrant pain, nausea after fatty meals, and jaundice
US$ 25.40
US$ 24.00
US$ 22.92
US$ 23.69
US$ 24.39
US$ 26.36
